Abivax (ABVX) Interest Expenses (2024 - 2026)
Abivax (ABVX) posted quarterly Interest Expenses of -$5.6 million for Q1 2026, up 21.05% year-over-year from -$4.6 million in Q1 2025, and down 102.24% quarter-over-quarter from $249.4 million in Q4 2025.
Abivax (ABVX) Interest Expenses (2024 - 2026) Analysis & Trends
Abivax's Interest Expenses history runs 3 years deep, the most recent figure standing at -$5.6 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 21.05% year-over-year to -$5.6 million; the TTM figure through Mar 2026 stood at $358.7 million (up 683.9% YoY), while the FY2025 annual figure was $130.1 million, up 616.4% from the prior year.
- Interest Expenses for Q1 2026 stood at -$5.6 million, down from $249.4 million in the prior quarter.
- The five-year high for Interest Expenses was $249.4 million in Q4 2025, with the low at -$7.1 million in Q1 2025.
- The 3-year median for Interest Expenses is $7.6 million (2024), against an average of $45.4 million.
- Peak annual rise in Interest Expenses reached 1068.9% in 2025, while the deepest fall reached 253.96% in 2025.
- Abivax's Interest Expenses stood at $35.9 million in 2024, then soared by 594.14% to $249.4 million in 2025, then tumbled by 102.24% to -$5.6 million in 2026.
- Business Quant data shows ABVX's Interest Expenses at -$5.6 million in Q1 2026, $249.4 million in Q4 2025, and $108.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | -5.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.58 Mn |
| Mar 31, 2026 | -5.58 Mn |
| Dec 31, 2025 | 249.36 Mn |
| Dec 31, 2025 | 249.36 Mn |
| Sep 30, 2025 | 108.78 Mn |
| Sep 30, 2025 | 108.78 Mn |
| Jun 30, 2025 | 6.13 Mn |
| Jun 30, 2025 | 6.13 Mn |
| Mar 31, 2025 | -7.07 Mn |
| Mar 31, 2025 | -7.07 Mn |
| Dec 31, 2024 | 35.92 Mn |
| Dec 31, 2024 | 35.92 Mn |
| Sep 30, 2024 | 9.31 Mn |
| Sep 30, 2024 | 9.31 Mn |
| Jun 30, 2024 | 7.60 Mn |
| Jun 30, 2024 | 7.60 Mn |
| Mar 31, 2024 | 4.59 Mn |
| Mar 31, 2024 | 4.59 Mn |